| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 16 |
| 1 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 15 |
| 2 | PANTOPRAZOLE | 15 |
| 3 | FLUOXETINE HYDROCHLORIDE | 14 |
| 4 | LINAGLIPTIN | 14 |
| 5 | FLUOXETINE | 13 |
| 6 | LAMIVUDINE | 13 |
| 7 | LAMIVUDINE ORAL | 13 |
| 8 | CANDESARTAN | 12 |
| 9 | DOLUTEGRAVIR SODIUM | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 15 | 0.0042 |
| 1 | DOLUTEGRAVIR SODIUM | 9 | 0.0010 |
| 2 | LINAGLIPTIN | 14 | 0.0008 |
| 3 | VECURONIUM BROMIDE | 1 | 0.0007 |
| 4 | DESFLURANE | 1 | 0.0006 |
| 5 | LAMIVUDINE | 13 | 0.0005 |
| 6 | BRODALUMAB | 1 | 0.0005 |
| 7 | CANDESARTAN | 12 | 0.0003 |
| 8 | IVERMECTIN | 1 | 0.0002 |
| 9 | GLYCOPYRROLATE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 14 | 0.0004 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0003 |
| 3 | Antiparasitic [EPC] | 1 | 0.0002 |
| 4 | Pediculicide [EPC] | 1 | 0.0002 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0001 |
| 6 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 8 | beta3-Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 5 | 0.0000 |